NIBP Validation Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

189 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-23

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial for Subject Group 2 and 3, and radial or umbilical arterial line for neonates (A-line) in critical care patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Philips Non-Invasive Blood Pressure Validation Study of VS30 Monitor

NCT06980766

Non Invasive Blood Pressure

COMPLETED

Comparison of Non-Invasive Blood Pressure (NIBP) Using the Biobeat Device with an Invasive Arterial Line Catheter

NCT04071015

Blood Pressure Heart Diseases

RECRUITING

Comparison of the Non-invasive Biobeat Device With an Invasive Arterial Line

NCT03603860

Blood Pressure Heart Diseases

COMPLETED

Hypertension Management Using Remote Patient Monitoring: Study 2

NCT04764318

Hypertension

COMPLETED

Non-invasive and Continuous Blood Pressure Monitoring

NCT06887465

Blood Pressure

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A multi-center, multi-phase, prospective, self-controlled, observational study.

* Phase I - A pilot phase designed for feasibility and the potential for algorithm development (enhancement).
* Phase II - Pivotal Phase: At the completion of Phase I -and finalization of the algorithm (if applicable), Phase II is designed for the purpose of establishing equivalence of the Philips NIBP system with the gold standard radial or umbilical (neonates) arterial line.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subject Group 1

Neonates, Infant, Children \<3 years of age

Philips IntelliVue X3 Patient Monitor

Intervention Type DEVICE

All subjects enrolled in this study will receive one Philips non-invasive blood pressure cuff. This cuff will be connected via compatible hose to the Philips IntelliVue X3 monitor hosting the released or investigational NIBP algorithm. The invasive blood pressure from the radial arterial line will also be connected to the Philips IntelliVue X3 monitor. The Philips IntelliVue X3 monitor will in turn be connected to a laptop for data collection.

Subject Group 2

Children 3-12 years of age

Philips IntelliVue X3 Patient Monitor

Intervention Type DEVICE

All subjects enrolled in this study will receive one Philips non-invasive blood pressure cuff. This cuff will be connected via compatible hose to the Philips IntelliVue X3 monitor hosting the released or investigational NIBP algorithm. The invasive blood pressure from the radial arterial line will also be connected to the Philips IntelliVue X3 monitor. The Philips IntelliVue X3 monitor will in turn be connected to a laptop for data collection.

Subject Group 3

Adolescent/Adult \>12 years of age

Philips IntelliVue X3 Patient Monitor

Intervention Type DEVICE

All subjects enrolled in this study will receive one Philips non-invasive blood pressure cuff. This cuff will be connected via compatible hose to the Philips IntelliVue X3 monitor hosting the released or investigational NIBP algorithm. The invasive blood pressure from the radial arterial line will also be connected to the Philips IntelliVue X3 monitor. The Philips IntelliVue X3 monitor will in turn be connected to a laptop for data collection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Philips IntelliVue X3 Patient Monitor

All subjects enrolled in this study will receive one Philips non-invasive blood pressure cuff. This cuff will be connected via compatible hose to the Philips IntelliVue X3 monitor hosting the released or investigational NIBP algorithm. The invasive blood pressure from the radial arterial line will also be connected to the Philips IntelliVue X3 monitor. The Philips IntelliVue X3 monitor will in turn be connected to a laptop for data collection.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient admitted into the NICU, PICU, ICU, or OR (operating room)
* Adult aged 18 years and older, or parent/legal guardian of minor, willing and able to understand and provide informed consent/assent
* Indication for NIBP cuff
* Indication for radial arterial line for Subject Group 2 and Subject Group 3, and radial or umbilical arterial line for Subject Group 1
* Meet the following stratification criteria across the study:

Stratification (per the ISO 81060-2:2018/Amd-2:2024):

* Subject Group 1:

* At least 3 patients shall be \<1000 g in weight
* At least 3 patients shall be 1000 to 2000 g in weight
* At least 3 patients shall be \> 2000 g in weight
* At least 3 patients shall be ≥ 29 days and \< 1 year of age
* At least 3 patients shall be ≥ 1 year and \< 3 years of age
* The remaining patients may be from any of the above age or weight groups in order to complete the sample size
* A patient can be in more than one category simultaneously
* Subject Group 2:

* At least 30% male, 30% female
* Limb circumference distributed as specified in ISO81060-2:2018/Amd2:2024.
* Subject Group 3:

* At least 30% male, 30% female
* Limb circumference distributed as specified in ISO81060- 2:2018/Amd-2:2024.
* At least 10% SBP ≤ 100mmHg
* At least 10% SBP ≥ 160mmHg
* At least 10% DBP ≤ 70mmHg
* At least 10% DBP ≥ 85mmHg

Exclusion Criteria

* Inability to place the study device appropriately due to patient's anatomy or condition
* Known pregnancy or lactating women (self-report)
* Patients treated with an intra-aortic balloon pump
* Aortic and mitral regurgitation (\> 2 nd degree)
* Measurements taken in the lateral position
* Currently participating in another clinical trial with any product, treatment and/or medication that clinically interferes with the study endpoint(s)
* If valid SBP reference measurements for lateral difference is \> 15 mmHg (except for neonates with umbilical A-line)
* If valid DBP reference measurements for lateral difference is \> 10 mmHg (except for neonates with umbilical A-line)
* At the Principal Investigator's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above

Eligible Sex

ALL

Accepts Healthy Volunteers

No